PS240 Clinical and Hemodynamic Analysis of the Treatment With Ivabradine in Severe Aortic Stenosis

Aortic stenosis is the most common valvular disease. Aortic valve replacement reduce mortality, but 33-50% of patients (pts) reject the intervention. No drug was shown to reduce mortality, but a high % of pts use beta blockers (BB), a negative inotropic drug. As in other cardiac pathologies, we assume that the reduction of heart rate (HR) in symptomatic severe aortic stenosis (SSAS) could be beneficial. We reduce HR with ivabradine, and change BB by ivabradine, safe drug without negative inotropic effect.

Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: G.A. Cortez Quiroga, C. Rus Mansilla, M.C. Duran Torralba, L. Lucas, J. Curotto Grasiosi, M.G. Lop éz Moyano, E. Ruiz De Temiño De Andres, C. Recuerda Casado, A. Sanchez Floro, L. Martinez Llavero Tags: Poster Abstract Source Type: research